Results from 42 patients with polymyalgia rheumatica or temporal arteritis showed that serum calprotectin levels are highly correlated with the acute phase clinical manifestations of the disease and its related parameters such as ESR, CRP, etc., and calprotectin levels were significantly decreased after the treatment with glucocorticoids [31]. The gene discussed is ESR1; the disease is polymyalgia rheumatica.